Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori proteins and adhesins represent a collective group of virulence factors and metabolic enzymes that enable the bacterium to survive and colonize the human gastric mucosa. A central component is Urease, an enzyme that catalyzes the hydrolysis of urea into ammonia and carbon dioxide, effectively neutralizing local gastric acid to create a habitable niche (StatPearls, 2023). Adhesins such as Blood group antigen-binding adhesin (BabA) and Sialic acid-binding adhesin (SabA) facilitate persistent colonization by binding to specific receptors on gastric epithelial cells (PubMed, 2021). Pathogenic strains often express Cytotoxin-associated gene A (CagA) and Vacuolating cytotoxin A (VacA), which manipulate host cell signaling, induce inflammation, and contribute to oncogenesis (UniProt, 2024). Therapeutic strategies primarily involve combination antibiotic regimens (e.g., clarithromycin, amoxicillin) that target bacterial protein synthesis and cell wall integrity, alongside proton pump inhibitors to enhance drug efficacy (NIH, 2023). These proteins are critical targets for both eradication of infection and the prevention of gastric cancer and peptic ulcers.
Inhibition of bacterial cell wall synthesis, inhibition of protein synthesis (50S/30S ribosomal subunits), inhibition of DNA gyrase, and inhibition of urease activity to prevent acid neutralization.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori proteins and adhesins (H. pylori proteins).